Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of amyotrophic lateral sclerosis (ALS). The designation ...
The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb trial of its oral NLRP3 inflammasome inhibitor, Usnoflast, for ...
Zydus, a leading, discovery-based, global pharmaceutical company announced that the US FDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for the treatment of ...
MG University Result 2025: Mahatma Gandhi University (MGU) Nalgonda has recently declared the semester results for various courses like BA, BSc, BCom, LLB, and other exams. Mahatma Gandhi ...
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...
Skip More from 5 Live... What Elis James and John Robins got up to in 2024 It’s time to recap on some of Elis James and John Robins' best moments of 2024. Six things we didn't know about being a ...
MG is a brand that’s rapidly on the up. Between 2021 and 2023, it has seen a hefty 64 per cent growth in its sales, lifting the brand from 18,000 sales in 2020 to 81,000 last year. Cars like ...
The Renault 5 isn’t the first car from a bygone era to make a comeback, but we reckon it could prove just as successful as other efforts (including the reimagined Fiat 500 and Mini). Indeed, the ...
Zydus Lifesciences has been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 2b trial testing its experimental oral treatment usnoflast in people with amyotrophic lateral ...
Bino Pathiparampil, Head of Research, Elara Capital, says companies like Dr Reddy’s, Zydus, Cipla, Sun, can sustain a low-double digit EPS growth over the medium term. Low-double digit is 11%, 12%, 13 ...